Expression of B7-1 by Pam 212 squamous cell carcinoma enhances tumor cell interactions with dendritic epidermal T cells but does not affect in vivo tumor growth

Journal of Investigative Dermatology

Volumn 109, Issue 6, 1997, Pages 728-733

  Yeh, Kun Yun ^a   Chen, Zhong ^a,d   Nasir, Adnan ^a   Ohsuga, Yasuko ^a   Takashima, Akira ^b   Lord, Edith M ^a   Gaspari, Anthony A ^a,c  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^b UNIVERSITY OF TEXAS AT DALLAS   (United States)

^c UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^d NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS   (United States)

Author keywords

Costimulation; Immunotherapy; Skin cancer

Indexed keywords

B7 ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; CHROMIUM 51 RELEASE; CONTROLLED STUDY; CYTOLYSIS; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; FEMALE; LYMPHOCYTE PROLIFERATION; LYMPHOKINE ACTIVATED KILLER CELL; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; TUMOR GROWTH;

EID: 0031450588     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1111/1523-1747.ep12340723     Document Type: Article

References (39)

1. Baher DW, Lord EM: Dimethylsulfoxide induces expression of H-2 antigens on mouse lung carcinoma cells. J Immunol 134:2790-2798, 1985
2. Baskar S, Nabavi N, Glimcher LH, Ostrand-Rosenberg S: Tumor cells expressing major histocompatibility complexes class II and B7 activation molecules stimulate potent tumor-specific immunity. J Immunother 14:209-215, 1993a
3. Baskar S, Ostrand-Rosenberg S, Nabavi N, Nadler LM, Freeman GJ, Glimcher LH: Constitutive expression of B7 restores immunogenicity of tumor cells expressing truncated major histocompatibility complex class II molecules. Proc Natl Acad Sci USA 90:5687-5690, 1993b
4. Blieden TM, McAdam AJ, Frelinger JG, Lord EM: Mechanism of cytolytic T lymphocyte killing of a low class I-expressing tumor. J Immunol 147: 1433-1438, 1991
5. Caughman SW, Breathnach SM, Sharrow SO, Stephany DA, Katz SI: Culture and characterization of murine dendritic Thy-1+ epidermal cells. J Invest Dermat 86:615-624, 1986
6. Chen L, Ashe S, Brady WA, et al: Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4. Cell 71:1093-1102, 1992
7. Chen Z, Rosten SI, Lord EM, Gaspari AA: Murine Pam 212 cutaneous squamous cell carcinoma is nonimmunogenic in normal syngeneic hosts and resistant to immune effector mechanisms. Reg Immunol 5:285-292, 1993
8. Chen L, McCowan P, Ashe S, Johnston J, Li Y, Hellstrom I, Hellstrom KE: Tumor immunogenicity determines the effect of B7 costimulation on T cell-mediated tumor immunity. J Exp Med 179:523-532, 1994
9. Chen Z, Knepper JE, Gaspari AA: Minor histocompatibility antigen-dependent rejection of Pam 212 epidermoid carcinoma by DBA 2 mice. Cell Immunol 164:90-99, 1995
10. Damle NK, Klussman K, Linsley PS, Aruffo A: Differential costimulatory effects of adhesion molecules B7. ICAM-1, LFA-3, and VCAM-1 on resting and antigen- primed CD4+ T lymphocytes J Immunol 148:1985-1992, 1992
11. Freeman GJ, Gray GS, Gimmi CD, et al: Structure, expression, and T cell costimulatory activity of the murine homologue of the human B lymphocytr activation antigen B7. J Exp Med 174:625-631, 1991
12. Gascoigne NR, Chien Y, Becker DM, Kavaler J, Davis MM: Genomic organization and sequence of T-cell receptor beta-chain constant- and joining-region genes. Nature 310:387-391, 1984
13. Gaspari AA, Ferbel B, Frelinger JG: Thy 1+ dendritic epidermal cells but not Langerhans cells express Ly 48. J Invest Dermatol 100:247-253, 1993
14. Gross JA, Callas E, Allison JP: Identification and distribution of the costimulatory receptor CD28 in the mouse. J Immunol 149:380-388, 1992
15. Havran WL, Chien YH, Allison JP: Recognition of self antigens by skin-derived T cells with invariant gamma delta antigen receptors. Science 252:1430-1432.
16. Huber H, Descossy P, van Brandwijk R, Knop J: Activation of murine epidermal TCR-gamma delta+ T cells by keratinocytes treated with sensitizers. J Immunol 155:2888-2894, 1995
17. June CH, Ledbetter JA, Linsley PS, Thompson CB: Role of the CD28 receptor in T-cell activation. Immunol Today 11:211-216, 1990
18. Kaminski MJ, Cruz PD, Bergstresser PR, Takashima A: Killing of skin-derived tumor cells by mouse dendritic epidermal T cells. Cancer Res 53:4014-4019, 1993
19. Kiessling R, Petranyi G, Klein G, Wigzel H. Genetic variation of in vitro cytolytic activity and in vivo rejection potential of non-immunized semi-syngeneic mice against a mouse lymphoma line. Int J Cancer 15:933-940, 1975
20. Kubota K, Katoh H: Cessation of autonomous proliferation of mouse lymphoma EI-4 by fusion with a T cell line. Int J Cancer 45:540-545, 1990
21. Kobata T, Shinkai Y, Iigo Y, et al: Thy-1-positive dendritic epidermal cells contain a killer protein perforin. Internat Immunol 2:1113-1116, 1990
22. Kuziel WA, Takashima A, Bonyhadi M, Bergstresser PR, Allison JP, Tigelaar RE, Tucker PW: Regulation of T-cell receptor gamma-chain RNA expression in murine Thy-1+ dendritic epidermal cells. Purification of functional active epidermal Langerhans cells: a simple and efficient new technique. Nature 328:263-266, 1987
23. Li Y, Newby AS, Johnston JV, Hellstrom KE, Chen I: Protective immunity induced by B7/CD28-costimulated gamma delta T cells to the EI-4 lymphoma in allogenic athymic mice. J Immunol 155:5705-5710, 1995
24. Linsley PS, Clark EA, Ledbetter JA: T-cell antigen CD28 mediates adhesion with B cells by interacting with activation antigen B7/BB-1. Proc Natl Acad Sci USA 87:5031-5035, 1990
25. Mohamadzadeh M, McGuire MJ, Smith DJ, Gaspari AA, Bergstresser PR, Takashima A: Functional roles for granzymes in murine epidermal γ δ T cell-mediated killing of tumor targets. J Invest Dermatol 107:738-742, 1996
26. Nasir A, Ferbel B, Salminen W, Barth RK, Gaspari AA: Exaggerated and persistent cutaneous delayed-type hypersensitivity in transgenic mice whose epidermal keratinocytes constitutively express B7-1 antigen. J Clin Invest 94:892-898, 1994
27. Nixon-Fulton JL, Hackett J Jr, Bergstresser PR, Kumar V, Tigelaar RE: Phenotypic heterogeneity and cytotoxic activity of Con A and IL-2-stimulated cultures of mouse Thy-1+ epidermal cells. J Invest Dermatol 91:62-68, 1988
28. Okamoto H, Itoh K, Welsh E, Trial J, Platsoucis C, Bucana C, Kripke ML: In vitro cytotoxic activity of interleukin 2-dependent murine Thy-1+ dendritic epidermal cell lines. J Leukocyte Biol 43:502-508, 1988
29. Ramurathinam L, Castle M, Wu Y, Liu Y: T cell costimulation by BB1 induces CD8 T cell-dependent tumor rejection: an important role of B7/BB1 in the induction. recruitment, and effector function of antitumor T cells. J Exp Med 179:1205-1214, 1994
30. Rose JK, Buonocore L, Whitt MA: A new cationic liposome reagent mediating nearly quantitative transfection of animal cells. Biotechniques 10:520-525, 1991
31. Simon JC, Cruz PD Jr, Tigelaar RE, Sontheimer RD, Bergstresser PR: Adhesion molecules CD11a, CD18, and ICAM-1 on human epidermal Langerhans cells serve a functional role in the activation of alloreactive T cells. J Invest Dermat 96:148-151, 1991
32. Sperling AI, Linsley PS, Barett TA, Bluestone JA: CD28-mediated costimulation is necessary for the activation of T cell receptor-gamma delta+ T lymphocytes. J Immunol 151:6043-6050, 1993
33. Takashima A, Nixon-Fulton JL, Bergstresser PR, Tigelaar RE: Thy-1+ dendritic epidermal cells in mice: precursor frequency analysis and cloning of concanavalin A-reactive cells. J Invest Dermatol 90:671-678, 1988
34. Townsend SE, Allison JP: Tumor rejection after direct costimulation of CD8+ T cells by B7-transfected melanoma cells [see comments]. Science 259:368-370, 1993
35. Turka LA, Linsley PS, Lin H, et al: T-cell activation by the CD28 ligand B7 is required for cardiac allograft rejection in vivo. Proceedings of the Proc Natl Acad Sci USA 89:11102-11105, 1992
36. Vedel J, Vincendeau P, Benzian JH, Taieb A: Flow cytometry analysis of adhesion molecules on human Langerhans cells. Clin Exp Dermatol 17:240-245, 1992
37. Yeh KY, Pulaski BA, Woods ML, McAdam AJ, Gaspari AA, Frelinger JG, Lord EM: B7-1 enhances natural killer cell-mediated cytotoxicity and inhibits tumor growth of a poorly immunogenic murine carcinoma. Cell Immunol 165:217-224, 1995
38. Yuhas JM, Pazmino NH, Wagner E: Development of concomitant immunity in mice bearing the weakly immunogenic line 1 lung carcinoma. Cancer res 35:237-241, 1975
39. Yuspa SH, Hawley-Nelson P, Kochler B, Stanley JR: A survey of transformation markers in differentiating epidermal cell lines in culture. Cancer Res 40:4694-4703, 1980